Higher doses of antiplatelet agents inacute coronary syndromes and PCI:results of the CURRENT OASIS 7 Study Dr Marcus Flather Director Clinical Trials and Evaluation Unit,Deputy Director of Research Royal Brompton and Harefield NHS Foundation Trust Reader in Clinical Trials, Imperial College London 5 thUpdate in Cardiology and Cardiovascular Surgery,Antalya, TurkeySeptember